(Q42284027)

19 October 2017

title

Fidaxomicin inhibits toxin production in Clostridium difficile (English)

1 reference

19 October 2017

main subject

Clostridium difficile

0 references

author name string

Farah Babakhani

1

1 reference

19 October 2017

Laurent Bouillaut

2

1 reference

19 October 2017

Pamela Sears

3

1 reference

19 October 2017

Carlee Sims

4

1 reference

19 October 2017

Abraham Gomez

5

1 reference

19 October 2017

Abraham L Sonenshein

6

1 reference

19 October 2017

language of work or name

English

0 references

publication date

2 December 2012

1 reference

Journal of Antimicrobial Chemotherapy

19 October 2017

published in

1 reference

19 October 2017

volume

68

1 reference

19 October 2017

issue

3

1 reference

19 October 2017

page(s)

515-522

1 reference

The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Spores of Clostridium difficile clinical isolates display a diverse germination response to bile salts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Variations in TcdB Activity and the Hypervirulence of Emerging Strains of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Fidaxomicin is an inhibitor of the initiation of bacterial RNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Fidaxomicin inhibits spore production in Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Repression of Clostridium difficile toxin gene expression by CodY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

A mouse model of Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Diverse temperate bacteriophage carriage in Clostridium difficile 027 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

In-depth genetic analysis of Clostridium difficile PCR-ribotype 027 strains reveals high genome fluidity including point mutations and inversions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Emergence and Control of Fluoroquinolone-Resistant, Toxin A–Negative, Toxin B–Positive Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS450

21 January 2018

Identifiers

DOI

10.1093/JAC/DKS450

1 reference

19 October 2017

1 reference